Dr. Schvartsman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1400 Holcombe Blvd
Houston, TX 77030- Is this information wrong?
Education & Training
Paulista School of MedicineClass of 2012
Publications & Presentations
PubMed
- 22 citationsAssociation between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes.Gustavo Schvartsman, Angelica M. Gutierrez-Barrera, Juhee Song, Naoto T. Ueno, Susan K. Peterson
Cancer Medicine. 2017-10-10 - 170 citationsResponse rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo F. Benveniste
Lung Cancer. 2017-10-01 - 17 citationsTreatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patientsGustavo Schvartsman, Michael J. Wagner, Behrang Amini, Chrystia M. Zobniw, Van Anh Trinh
Scientific Reports. 2017-08-25
Lectures
- A phase II study of study of bevacizumab (BEV) in combination with atezolizumab (ATEZO) in pts (pts) with untreated melanoma brain metastases (BEAT-MBM).2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Outcomes of metastatic melanoma (MM) patients (pts) after discontinuation of anti-Programmed-Death 1 (PD1) therapy without disease progression.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
